Inventor · disambiguated record
Maria Praggastis
Also filed as: PRAGGASTIS MARIA
1 granted patent·6 pending applications·1 citations·filing 2019–2025
17Inventor score
Files withREGENERON PHARMA7
Top patents by PatentIndex Score
7 records- 0168US12258597B2Methods and compositions for therapeutic protein deliveryREGENERON PHARMA·Filed 2019·Granted Mar 25, 2025·1 cites·23 claims
- 0266US2023338477A1Anti-tfr:gaa and anti-cd63:gaa insertion for treatment of pompe diseaseREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0362US2025049896A1Anti-tfr:acid sphingomyelinase for treatment of acid sphingomyelinase deficiencyREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0462US2024052051A1Anti-tfr:payload fusions and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0558US2025041455A1Anti-tfr:gaa and anti-cd63:gaa insertion for treatment of pompe diseaseREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0652US2025197829A1Methods and compositions for therapeutic protein deliveryREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0751US2023220100A1Bbb-targeted gaa delivered as gene therapy treats cns and muscle in pompe disease model miceREGENERON PHARMA·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maria Praggastis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →